Geron Corporation

(GERN)

By |

Profile

Geron Corp is a biopharmaceutical company that supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc., or Janssen.

Contact Information

Website: www.geron.com
Main Phone: +1 650 473-7700
Address: 149 Commonwealth Drive
Address 2: Suite 2070
State: CA
City / Town: Menlo Park
Country: USA
Postal Code: 94025

Issuer Information

Exchange: NGS
Employees: 17
NAICS: Pharmaceutical P
$ 2.08 ($ 0.01) (-0.48%)
Last Price 2.08 Change $ -0.01 Change % -0.48 Tick N/A
Bid 2.06 Bid Size 200.00 Ask 2.49 Ask Size 1,000.00
Open 2.11 High 2.23 Low 2.06 Prev Close 2.09
Last Trade Volume 2 mi 52 Wk Hi 5.15 52 Wk Low 1.81
Market Cap 331 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 159,145,094.00 EPS (TTM) -0.18 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 4
Number of Buys 1 4
Number of Sells 0 0
Net Activity 4897 16859
Last 10 Buys Shares
Daniel M. Bradbury 1,000
John A. Scarlett 1,000
John A. Scarlett 1,000
Thomas D. Kiley 1,000
Thomas D. Kiley 1,000
Last 10 Sell Shares
Melissa A. Kelly Behrs 1,000
Olivia Bloom 1,000
Thomas Hofstaetter 1,000
Melissa A. Kelly Behrs 1,000
Olivia Bloom 1,000
Melissa A. Kelly Behrs 1,000
Olivia Bloom 1,000
Melissa A. Kelly Behrs 1,000
Melissa A. Kelly Behrs 1,000
Olivia Bloom 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 7.5 7.5 7.5 7.5
Standard Deviation 2.18 2.18 2.18 2.18
Date of Most Recent Estimate 08/04/16 08/04/16 05/08/16 08/12/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.5